Limited Competition: Data Analysis and Sharing Center (DASC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed)
The summary for the Limited Competition: Data Analysis and Sharing Center (DASC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition: Data Analysis and Sharing Center (DASC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed): The purpose of this Notice of Funding Opportunity (NOFO) is to renew the MACS/WIHS Combined Cohort Study of HIV in United States Adults (MWCCS) for a 7-year project period (2026-2033). Continuation of this epidemiological cohort study of middle-aged and older people living with HIV (PLWH), along with comparable individuals living without HIV (PLWOH) will enable the continued follow-up of a deeply phenotyped cohort of approximately 5,500 participants from across the United States. This initiative will utilize a populomics approach, i.e., examination of health determinants across multiple scales of influence (e.g. molecular, cellular, physiological, lifestyle/behavioral, household, neighborhood, environmental, cultural, and sociopolitical) using multi-disciplinary methods to investigate the web of influences impacting the health, quality of life, and survival of adults living with HIV. This NOFO seeks applications to fund a single Data Analysis and Sharing Center (DASC) for the MWCCS, with competition limited to institutions who were funded under RFA-HL-19-007.
| Federal Grant Title: | Limited Competition: Data Analysis and Sharing Center (DASC) for the MACS/WIHS Combined Cohort Study (MWCCS) (U01 Clinical Trials Not Allowed) |
| Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
| Grant Categories: | Education, Health, Income Security and Social Services |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-HL-26-010 |
| Type of Funding: | Cooperative Agreement |
| CFDA Numbers: | 93.121, 93.173, 93.233, 93.242, 93.273, 93.279, 93.307, 93.313, 93.361, 93.393, 93.837, 93.838, 93.839, 93.840, 93.855, 93.865, 93.866 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | May 2nd, 2025 |
| Original Application Deadline: | May 2nd, 2025 |
| Posted Date: | January 16th, 2025 |
| Creation Date: | January 16th, 2025 |
| Archive Date: | June 7th, 2025 |
| Total Program Funding: | $2,000,000 |
| Maximum Federal Grant Award: | $2,000,000 |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
| Last Updated: | January 16th, 2025 |
- Applicants Eligible for this Grant
- Public and State controlled institutions of higher education - Private institutions of higher education
- Additional Information on Eligibility
- Other Eligible Applicants include the following: See NOFO for further eligibility criteria. Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
- Link to Full Grant Announcement
- https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-26-010.html
- Grant Announcement Contact
- NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed...
- • NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial ...
- • Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
- • Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research ...
- • Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Scie...
- • Epidemiological and Behavioral Research in Oral Health
- • Metagenomic Analyses of the Oral Microbiome
- • Phase Iii Clinical Trials in Oral Infectious Diseases
- More Grants from the National Institutes of Health
- • Resource-Related Research Projects for Development of Models and Related Materials for Stu...
- • Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)
- • Informatics, Coordination and Service Center for the Mutant Mouse Resource and Research Ce...
- • Diabetes Research Centers (P30 Clinical Trial Optional)
- • Limited Competition Renewal for the Continuation of the Liver Cirrhosis Network: Clinical ...
